From Using Frugal Business Model, Orphagen Targets Orphan Receptors:

Orphagen Pharmaceuticals 2007 (300x200)
Orphagen Pharmaceuticals 2007 (300×200)

Orphagen Pharmaceuticals staff in 2007. CEO and founder Scott Thacher is second from left.